Half-year report · HY
3583.TEDINET S100WZXL
Period2025-04-01 → 2025-09-30
Filed2025-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥3.1bn | 2025-04-01 → 2025-09-30 | Cons. | Net sales |
| Revenue | ¥6.0bn | 2024-04-01 → 2025-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥3.0bn | 2024-04-01 → 2024-09-30 | Cons. | Net sales |
| Operating income | ¥352m | 2025-04-01 → 2025-09-30 | Cons. | Operating income |
| Operating income | ¥489m | 2024-04-01 → 2024-09-30 | Cons. | Operating income |
| Ordinary income | ¥351m | 2025-04-01 → 2025-09-30 | Cons. | Ordinary income |
| Ordinary income | ¥814m | 2024-04-01 → 2025-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥454m | 2024-04-01 → 2024-09-30 | Cons. | Ordinary income |
| Profit before tax | ¥353m | 2025-04-01 → 2025-09-30 | Cons. | Income before income taxes |
| Profit before tax | ¥452m | 2024-04-01 → 2024-09-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥355m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥580m | 2024-04-01 → 2025-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥302m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥355m | 2025-04-01 → 2025-09-30 | Cons. | Profit loss |
| Net income | ¥302m | 2024-04-01 → 2024-09-30 | Cons. | Profit loss |
| Total assets | ¥10.0bn | at 2025-09-30 | Cons. | Assets |
| Total assets | ¥9.8bn | at 2025-03-31 | Cons. | Assets |
| Total assets | ¥9.6bn | at 2024-09-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥3.0bn | at 2025-09-30 | Cons. | Liabilities |
| Total liabilities | ¥3.1bn | at 2025-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥7.0bn | at 2025-09-30 | Cons. | Net assets |
| Net assets / equity | ¥6.7bn | at 2025-03-31 | Cons. | Net assets |
| Net assets / equity | ¥6.5bn | at 2024-09-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.7bn | at 2025-09-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥2.9bn | at 2025-03-31 | Cons. | Cash and deposits |
| Cash & equivalents | ¥2.7bn | at 2025-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.8bn | at 2025-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.5bn | at 2024-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥2.8bn | at 2024-03-31v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥277m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥637m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥313m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥47m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥160m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥202m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥248m | 2025-04-01 → 2025-09-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥562m | 2024-04-01 → 2025-03-31 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥391m | 2024-04-01 → 2024-09-30 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥129.18 | 2025-04-01 → 2025-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥209.05 | 2024-04-01 → 2025-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥108.1 | 2024-04-01 → 2024-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 69.8% | at 2025-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 68.1% | at 2025-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 67.6% | at 2024-09-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 30
| Segment | Item | Period | Value |
|---|---|---|---|
| Medical Productsreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥829m |
| Medical Productsreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥827m |
| Medical Productsreportable segment | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥1m |
| Medical Productsreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥58m |
| Technological Productsreportable segment | revenue | 2025-04-01 → 2025-09-30 | ¥2.2bn |
| Technological Productsreportable segment | revenue external | 2025-04-01 → 2025-09-30 | ¥2.2bn |
| Technological Productsreportable segment | segment profit | 2025-04-01 → 2025-09-30 | ¥448m |
| —segment total | revenue | 2025-04-01 → 2025-09-30 | ¥3.1bn |
| —segment total | revenue external | 2025-04-01 → 2025-09-30 | ¥3.1bn |
| —segment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥1m |
| —segment total | segment profit | 2025-04-01 → 2025-09-30 | ¥507m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2025-04-01 → 2025-09-30 | ¥3.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2025-04-01 → 2025-09-30 | ¥3.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2025-04-01 → 2025-09-30 | ¥1m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2025-04-01 → 2025-09-30 | ¥507m |
| Medical Productsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥817m |
| Medical Productsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥817m |
| Medical Productsreportable segment | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥513,000 |
| Medical Productsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥65m |
| Technological Productsreportable segment | revenue | 2024-04-01 → 2024-09-30 | ¥2.2bn |
| Technological Productsreportable segment | revenue external | 2024-04-01 → 2024-09-30 | ¥2.2bn |
| Technological Productsreportable segment | segment profit | 2024-04-01 → 2024-09-30 | ¥598m |
| —segment total | revenue | 2024-04-01 → 2024-09-30 | ¥3.0bn |
| —segment total | revenue external | 2024-04-01 → 2024-09-30 | ¥3.0bn |
| —segment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥513,000 |
| —segment total | segment profit | 2024-04-01 → 2024-09-30 | ¥663m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-04-01 → 2024-09-30 | ¥3.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-04-01 → 2024-09-30 | ¥3.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-04-01 → 2024-09-30 | ¥513,000 |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-04-01 → 2024-09-30 | ¥663m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 531
| Item | Context | Value | Unit |
|---|---|---|---|
| Independent auditors report consolidated (text) | FilingDateInstant | Text · Plus | |
| Audit firm1 consolidated | FilingDateInstant | Original text (Japanese)監査法人グラヴィタス | |
| Cpa1 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)圓 岡 徳 樹 | |
| Cpa2 audit firm1 consolidated | FilingDateInstant | Original text (Japanese)飯 田 一 紀 | |
| Number of submission | FilingDateInstant | 1 | |
| Net sales (5-year summary) | Prior1InterimDuration | 2991292000 | JPY |
| Net sales (5-year summary) | InterimDuration | 3056514000 | JPY |
| Net sales (5-year summary) | Prior1YearDuration | 6035997000 | JPY |
| Ordinary income loss (5-year summary) | Prior1InterimDuration | 453726000 | JPY |
| Ordinary income loss (5-year summary) | InterimDuration | 350897000 | JPY |
| Ordinary income loss (5-year summary) | Prior1YearDuration | 814030000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1InterimDuration | 302335000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | InterimDuration | 354721000 | JPY |
| Profit loss attributable to owners of parent (5-year summary) | Prior1YearDuration | 580136000 | JPY |
| Comprehensive income (5-year summary) | Prior1InterimDuration | 292558000 | JPY |
| Comprehensive income (5-year summary) | InterimDuration | 373847000 | JPY |
| Comprehensive income (5-year summary) | Prior1YearDuration | 569222000 | JPY |
| Net assets (5-year summary) | Prior1InterimInstant | 6509308000 | JPY |
| Net assets (5-year summary) | InterimInstant | 6952160000 | JPY |
| Net assets (5-year summary) | Prior1YearInstant | 6707800000 | JPY |
| Total assets (5-year summary) | Prior1InterimInstant | 9625248000 | JPY |
| Total assets (5-year summary) | InterimInstant | 9961257000 | JPY |
| Total assets (5-year summary) | Prior1YearInstant | 9842848000 | JPY |
| Basic earnings loss per share (5-year summary) | Prior1InterimDuration | 108.10 | |
| Basic earnings loss per share (5-year summary) | InterimDuration | 129.18 | |
| Basic earnings loss per share (5-year summary) | Prior1YearDuration | 209.05 | |
| Diluted earnings per share (5-year summary) | Prior1InterimDuration | － | |
| Diluted earnings per share (5-year summary) | InterimDuration | － | |
| Diluted earnings per share (5-year summary) | Prior1YearDuration | － | |
| Equity to asset ratio (5-year summary) | Prior1InterimInstant | 0.676 | |
| Equity to asset ratio (5-year summary) | InterimInstant | 0.698 | |
| Equity to asset ratio (5-year summary) | Prior1YearInstant | 0.681 | |
| Net cash provided by used in operating activities (5-year summary) | Prior1InterimDuration | 312639000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | InterimDuration | 276866000 | JPY |
| Net cash provided by used in operating activities (5-year summary) | Prior1YearDuration | 637429000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1InterimDuration | -202285000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | InterimDuration | -46828000 | JPY |
| Net cash provided by used in investing activities (5-year summary) | Prior1YearDuration | -159736000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1InterimDuration | -391438000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | InterimDuration | -247796000 | JPY |
| Net cash provided by used in financing activities (5-year summary) | Prior1YearDuration | -561993000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1InterimInstant | 2548041000 | JPY |
| Cash and cash equivalents (5-year summary) | InterimInstant | 2742179000 | JPY |
| Cash and cash equivalents (5-year summary) | Prior1YearInstant | 2750379000 | JPY |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 3092623 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | 3092623 | |
| Number of issued shares as of fiscal year end issued shares total number of shares etc | FilingDateInstant | 3092623 | |
| Number of issued shares as of filing date issued shares total number of shares etc | FilingDateInstant | 3092623 | |
| Number of shares held | InterimInstant_No1MajorShareholdersMember | 471000 | |
| Shareholding ratio | InterimInstant_No1MajorShareholdersMember | 0.1561 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |